会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明专利
    • Eye drop for corneal epithelial defect treatment
    • 眼部上皮缺损治疗眼损伤
    • JP2012062269A
    • 2012-03-29
    • JP2010207110
    • 2010-09-15
    • Teika Seiyaku Kkテイカ製薬株式会社
    • SHIMATANI TAKAOKOBAYASHI MINORUARAKI TAKASHIARIKAWA CHIKAKO
    • A61K31/728A61K9/08A61K47/02A61K47/04A61K47/12A61K47/18A61P27/02
    • PROBLEM TO BE SOLVED: To provide a multi-dose type eye drop for corneal epithelial defect treatment containing hyaluronic acid at a high concentration of ≥0.3 w/v%, which has low cytotoxicity, is effectively prevented from decomposing thereby having high preservation efficacy and which has low irritation and satisfactory sense of use.SOLUTION: The multi-dose type eye drop for corneal epithelial defect treatment contains the following (a) to (c): (a) hyaluronic acid or its pharmacologically acceptable salt; (b) boric acid and/or borax; and (c) composed of the following (c1) and/or (c2): (c1) chlorhexidine or its pharmacologically acceptable salt; and (c2) p-hydroxy-benzoateester, wherein the blending quantity of the (a) hyaluronic acid or it pharmacologically acceptable salt is ≥0.3 w/v% to the whole of the formulation.
    • 要解决的问题:为了提供含有高浓度≥0.3w/ v%的透明质酸(其具有低细胞毒性)的角膜上皮缺损处理的多剂量眼滴,有效地防止了分解,从而具有高的 保鲜效果好,刺激性低,使用感好。 解决方案:角膜上皮缺损治疗的多剂量眼滴包含以下(a)至(c):(a)透明质酸或其药理学上可接受的盐; (b)硼酸和/或硼砂; 和(c)由以下(c1)和/或(c2)组成:(c1)氯己定或其药理学上可接受的盐; 和(c2)对羟基苯甲酸酯,其中(a)透明质酸或其药理学上可接受的盐的配合量相对于整个制剂为≥0.3w/ v%。 版权所有(C)2012,JPO&INPIT